Aveanna launches IPO
By HME News Staff
Updated 10:00 AM CDT, Tue April 20, 2021
ATLANTA – Aveanna Healthcare Holdings, a diversified home care platform that provides respiratory therapy products and services, has launched an initial public offering of about 38.2 million shares of its common stock at an anticipated initial public offering price of $16 to $18 per share. The company also intends to grant the underwriters a 30-day option to purchase up to an additional 5.7 million shares of its common stock. Aveanna has applied to list its common stock on the Nasdaq under the ricker symbol AVAH. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse are acting as joint lead book-running managers, and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets and Truist Securities are acting as book-running managers for the proposed offering. Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank are acting as co-managers for the proposed offering. Aveanna cares for patients and families in 25 states through a rapidly growing network of 200-plus branch offices. It offers respiratory therapy, enteral nutrition and medical supplies, as well as private-duty and home health and hospice services. The respiratory therapy products and services it provides include oxygen concentrators, CPAP devices and ventilators.
Comments